Clinical results of IMAT in adenocarcinoma prostate cancer

被引：0
作者：
Gribaudo, S. [1 ]
Monetti, U. [1 ]
Mussano, A. [1 ]
La Sala, S. [1 ]
Di Gregorio, S. [1 ]
Richetto, V. [1 ]
Sardo, A. [1 ]
Trevisiol, E. [1 ]
Madon, E. [1 ]
Urgesi, A. [1 ]
机构：
[1] OIRM, S Anna Hosp, Turin, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1079
引用
收藏
页码：S440 / S440
页数：1
相关论文
共 50 条
  • [31] Clinical behaviour of primary mucinous adenocarcinoma of the prostate
    Özsoy, O
    Girardet, C
    Pelte, MF
    Fioretta, G
    De Weck, D
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 141 - 141
  • [32] A CLINICAL AND IMMUNOHISTOCHEMICAL STUDY OF PAPILLARY ADENOCARCINOMA OF THE PROSTATE
    ITO, T
    FURUSATO, M
    AKIYAMA, A
    KATO, H
    AIZAWA, S
    [J]. PROSTATE, 1995, 26 (01) : 23 - 27
  • [33] Ductal adenocarcinoma of the prostate: Clinical and biological profiles
    Vinceneux, Armelle
    Bruyere, Franck
    Haillot, Olivier
    Charles, Thomas
    de la Taille, Alexandre
    Salomon, Laurent
    Allory, Yves
    Ouzaid, Idir
    Choudat, Laurence
    Roupret, Morgan
    Comperat, Eva
    Houede, Nadine
    Beauval, Jean-Baptiste
    Vourc'h, Patrick
    Fromont, Gaelle
    [J]. PROSTATE, 2017, 77 (12) : 1242 - 1250
  • [34] Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer
    Huang, Gang
    Zhang, Huaru
    Shi, Haoqing
    Zhang, Wenhui
    Wang, Tao
    Wang, Ziwei
    Chen, Qing
    Lian, Bijun
    Li, Jing
    Yang, Guosheng
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [35] Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer
    Gang Huang
    Huaru Zhang
    Haoqing Shi
    Wenhui Zhang
    Tao Wang
    Ziwei Wang
    Qing Chen
    Bijun Lian
    Jing Li
    Guosheng Yang
    [J]. World Journal of Surgical Oncology, 20
  • [36] Early biomarkers related to secondary primary cancer risk in radiotherapy treated prostate cancer patients: IMRT versus IMAT
    Werbrouck, Joke
    Ost, Piet
    Fonteyne, Valerie
    De Meerleer, Gert
    De Neve, Wilfried
    Bogaert, Evelien
    Beels, Laurence
    Bacher, Klaus
    Vral, Anne
    Thierens, Hubert
    [J]. RADIOTHERAPY AND ONCOLOGY, 2013, 107 (03) : 377 - 381
  • [37] Overall treatment time and toxicity of IMAT with integrated boost for intermediate or high-risk prostate cancer
    Ferrer, F.
    Mendez, M.
    Letelier, H.
    Boladeras, A.
    Pineiro, R.
    Chiruzzi, C.
    Galdeano, M.
    Najjari, D.
    Sancho, I.
    Chavez, R.
    Picon, C.
    Pera, J.
    Guedea, F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S665 - S665
  • [38] Step & shoot IMAT for the prostate, more beams, less QA
    Meijer, G.
    Janssen, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S380 - S380
  • [39] Urotensin II Receptor Predicts the Clinical Outcome of Prostate Cancer Patients and Is Involved in the Regulation of Motility of Prostate Adenocarcinoma Cells
    Grieco, Paolo
    Franco, Renato
    Bozzuto, Giuseppina
    Toccacieli, Laura
    Sgambato, Alessandro
    Marra, Monica
    Zappavigna, Silvia
    Migaldi, Mario
    Rossi, Giulio
    Striano, Stefano
    Marra, Luigi
    Gallo, Luigi
    Cittadini, Achille
    Botti, Gerardo
    Novellino, Ettore
    Molinari, Agnese
    Budillon, Alfredo
    Caraglia, Michele
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2011, 112 (01) : 341 - 353
  • [40] UROTENSIN II RECEPTOR IS INVOLVED IN THE REGULATION OF MOTILITY OF PROSTATE ADENOCARCINOMA CELLS AND PREDICTS THE CLINICAL OUTCOME OF PROSTATE CANCER PATIENTS
    Caraglia, M.
    Marra, M.
    Franco, R.
    Sgambato, A.
    Zappavigna, S.
    Striano, S.
    Marra, L.
    Gallo, L.
    Botti, G.
    Ferro, M.
    Altieri, V.
    Novellino, E.
    Molinari, A.
    Budillon, A.
    Grieco, P.
    [J]. ANTICANCER RESEARCH, 2010, 30 (04) : 1531 - 1532
12345